Karachi: Highnoon Laboratories Limited has scheduled a Board of Directors’ meeting for October 28, 2024, at its corporate office in Lahore to discuss and potentially approve its unaudited financial statements for the third quarter which ended on September 30, 2024.

The meeting is set to take place at Karachi, as revealed in a notice sent to the Pakistan Stock Exchange Limited. This session will not only cover the financial outcomes of the quarter but also address other unspecified agenda items.

According to information available from the Pakistan Stock Exchange (PSX), the company has initiated a "Closed Period" from October 22 to October 28, 2024. During this time, no director, CEO, or executive shall engage directly or indirectly in any dealings with the company’s shares. This protocol follows Clause 5.6.1(d) of the Rule Book of the Exchange, aiming to prevent any insider trading or conflict of interest during the pivotal financial review period.

Highnoon has been recognized as one of the best companies under a billion by Forbes Asia in 2023, reflecting its substantial growth and operational success in recent years. The outcomes of this upcoming board meeting are highly anticipated, as stakeholders look to gauge the company's current financial health and strategic direction heading into the final quarter of 2024.